Male-specific, replicable and functional roles of genetic variants and cerebral gray matter volumes in ADHD: a gene-wide association study across KTN1 and a region-wide functional validation across brain
- PMID: 36609385
- PMCID: PMC9824933
- DOI: 10.1186/s13034-022-00536-0
Male-specific, replicable and functional roles of genetic variants and cerebral gray matter volumes in ADHD: a gene-wide association study across KTN1 and a region-wide functional validation across brain
Abstract
Attention deficit hyperactivity disorder (ADHD) is associated with reduction of cortical and subcortical gray matter volumes (GMVs). The kinectin 1 gene (KTN1) has recently been reported to significantly regulate GMVs and ADHD risk. In this study, we aimed to identify sex-specific, replicable risk KTN1 alleles for ADHD and to explore their regulatory effects on mRNA expression and cortical and subcortical GMVs. We examined a total of 1020 KTN1 SNPs in one discovery sample (ABCD cohort: 5573 males and 5082 females) and three independent replication European samples (Samples #1 and #2 each with 802/122 and 472/141 male/female offspring with ADHD; and Sample #3 with 14,154/4945 ADHD and 17,948/16,246 healthy males/females) to identify replicable associations within each sex. We examined the regulatory effects of ADHD-risk alleles on the KTN1 mRNA expression in two European brain cohorts (n = 348), total intracranial volume (TIV) in 46 European cohorts (n = 18,713) and the ABCD cohort, as well as the GMVs of seven subcortical structures in 50 European cohorts (n = 38,258) and of 118 cortical and subcortical regions in the ABCD cohort. We found that four KTN1 variants significantly regulated the risk of ADHD with the same direction of effect in males across discovery and replication samples (0.003 ≤ p ≤ 0.041), but none in females. All four ADHD-risk alleles significantly decreased KTN1 mRNA expression in all brain regions examined (1.2 × 10-5 ≤ p ≤ 0.039). The ADHD-risk alleles significantly increased basal ganglia (2.8 × 10-22 ≤ p ≤ 0.040) and hippocampus (p = 0.010) GMVs but reduced amygdala GMV (p = 0.030) and TIV (0.010 < p ≤ 0.013). The ADHD-risk alleles also significantly reduced some cortical (right superior temporal pole, right rectus) and cerebellar but increased other cortical (0.007 ≤ p ≤ 0.050) GMVs. To conclude, we identified a set of replicable and functional risk KTN1 alleles for ADHD, specifically in males. KTN1 may play a critical role in the pathogenesis of ADHD, and the reduction of specific cortical and subcortical, including amygdalar but not basal ganglia or hippocampal, GMVs may serve as a neural marker of the genetic effects.
Keywords: ABCD; ADHD; Basal ganglia; Cortex; Gray matter volume (GMV); KTN1.
© 2023. The Author(s).
Conflict of interest statement
There is no conflict of interest to declare
Similar articles
-
A significant, functional and replicable risk KTN1 variant block for schizophrenia.Sci Rep. 2023 Mar 8;13(1):3890. doi: 10.1038/s41598-023-27448-z. Sci Rep. 2023. PMID: 36890161 Free PMC article.
-
Sex-different interrelationships of rs945270, cerebral gray matter volumes, and attention deficit hyperactivity disorder: a region-wide study across brain.Transl Psychiatry. 2022 Jun 2;12(1):225. doi: 10.1038/s41398-022-02007-8. Transl Psychiatry. 2022. PMID: 35654767 Free PMC article.
-
A novel risk variant block across introns 36-45 of CACNA1C for schizophrenia: a cohort-wise replication and cerebral region-wide validation study.Psychiatr Genet. 2023 Oct 1;33(5):182-190. doi: 10.1097/YPG.0000000000000344. Epub 2023 Jun 16. Psychiatr Genet. 2023. PMID: 37706495 Free PMC article.
-
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x. Respir Res. 2024. PMID: 39709425 Free PMC article. Review.
-
Defining disease severity in atopic dermatitis and psoriasis for the application to biomarker research: an interdisciplinary perspective.Br J Dermatol. 2024 Jun 20;191(1):14-23. doi: 10.1093/bjd/ljae080. Br J Dermatol. 2024. PMID: 38419411 Free PMC article. Review.
Cited by
-
The Role of 3' Regulatory Region Flanking Kinectin 1 Gene in Schizophrenia.Alpha Psychiatry. 2024 Jun 1;25(3):413-420. doi: 10.5152/alphapsychiatry.2024.241616. eCollection 2024 Jun. Alpha Psychiatry. 2024. PMID: 39148597 Free PMC article.
-
The effects of alcohol use severity and polygenic risk on gray matter volumes in young adults.Front Psychiatry. 2025 May 13;16:1560053. doi: 10.3389/fpsyt.2025.1560053. eCollection 2025. Front Psychiatry. 2025. PMID: 40433172 Free PMC article.
-
The effects of alcohol use severity and polygenic risk on gray matter volumes in young adults.medRxiv [Preprint]. 2025 Jan 20:2025.01.20.25320842. doi: 10.1101/2025.01.20.25320842. medRxiv. 2025. Update in: Front Psychiatry. 2025 May 13;16:1560053. doi: 10.3389/fpsyt.2025.1560053. PMID: 39974144 Free PMC article. Updated. Preprint.
References
-
- Silk TJ, Beare R, Malpas C, Adamson C, Vilgis V, Vance A, Bellgrove MA. Cortical morphometry in attention deficit/hyperactivity disorder: contribution of thickness and surface area to volume. Cortex. 2016;82:1–10. - PubMed
-
- Curatolo P, Paloscia C, D'Agati E, Moavero R, Pasini A. The neurobiology of attention deficit/hyperactivity disorder. Eur J Paediatr Neurol. 2009;13(4):299–304. - PubMed
-
- Carmona S, Vilarroya O, Bielsa A, Tremols V, Soliva JC, Rovira M, Tomas J, Raheb C, Gispert JD, Batlle S, et al. Global and regional gray matter reductions in ADHD: a voxel-based morphometric study. Neurosci Lett. 2005;389(2):88–93. - PubMed
-
- Makris N, Biederman J, Valera EM, Bush G, Kaiser J, Kennedy DN, Caviness VS, Faraone SV, Seidman LJ. Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb Cortex. 2007;17(6):1364–1375. - PubMed
-
- Seidman LJ, Valera EM, Makris N, Monuteaux MC, Boriel DL, Kelkar K, Kennedy DN, Caviness VS, Bush G, Aleardi M, et al. Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging. Biol Psychiat. 2006;60(10):1071–1080. - PubMed
Grants and funding
- R01 MH062873/MH/NIMH NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- R13 MH059126/MH/NIMH NIH HHS/United States
- K23 MH001966/MH/NIMH NIH HHS/United States
- R01 NS054124/NS/NINDS NIH HHS/United States
- K24 MH001805/MH/NIMH NIH HHS/United States
- K24 DA016264/DA/NIDA NIH HHS/United States
- U01 MH085518/MH/NIMH NIH HHS/United States
- R01 MH063706/MH/NIMH NIH HHS/United States
- R01 MH066237/MH/NIMH NIH HHS/United States
- K08 MH001503/MH/NIMH NIH HHS/United States
- R01 MH081803/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources